Handelsbanken Fonder AB - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$521
-22.8%
14,6230.0%0.00%
-25.0%
Q2 2023$675
-4.5%
14,623
-17.0%
0.00%0.0%
Q1 2023$707
+24.9%
17,623
+44.2%
0.00%0.0%
Q4 2022$566
-99.9%
12,223
+16.2%
0.00%
+33.3%
Q3 2022$436,000
-30.6%
10,5230.0%0.00%
-25.0%
Q2 2022$628,000
-17.8%
10,5230.0%0.00%0.0%
Q1 2022$764,000
-13.7%
10,5230.0%0.00%0.0%
Q4 2021$885,000
-6.7%
10,5230.0%0.00%
-20.0%
Q3 2021$949,000
-5.4%
10,5230.0%0.01%0.0%
Q2 2021$1,003,000
-20.8%
10,523
-5.4%
0.01%
-28.6%
Q1 2021$1,266,000
-8.7%
11,123
+11.0%
0.01%
-12.5%
Q4 2020$1,387,000
+68.3%
10,0230.0%0.01%
+33.3%
Q3 2020$824,000
-38.9%
10,023
-41.9%
0.01%0.0%
Q2 2020$1,348,000
+137.3%
17,246
+115.6%
0.01%
-64.7%
Q3 2016$568,000
+45.3%
8,0000.0%0.02%
+6.2%
Q2 2016$391,000
-22.7%
8,0000.0%0.02%
-27.3%
Q1 2016$506,000
-71.8%
8,000
-50.0%
0.02%
-37.1%
Q4 2015$1,795,00016,0000.04%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2022
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders